LENZ LENZ Therapeutics, Inc. | US52635N1037
| Metric | Current | 31.03.2026 | 31.12.2025 | 30.09.2025 |
|---|---|---|---|---|
| Market Cap | 171.822.080 | 286.892.693,14 | 501.516.512 | 1.331.641.249,73 |
| Enterprise Value | -85.889.920 | 262.793.693,14 | 477.152.512 | 1.307.196.249,73 |
| Trailing P/E | - | - | - | - |
| Forward P/E | -1,56 | - | - | - |
| Price to Sales | 8,19 | 13,67 | 26,27 | 76,09 |
| Price to Book | 0,7 | 1,16 | 1,76 | 6,87 |
| EV/Revenue | -4,09 | 12,52 | 25 | 74,7 |
| EV/EBITDA | 0,73 | - | - | - |